ION269
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ION269, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD) [Phase 1]